Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis. (Q51025492)
Jump to navigation
Jump to search
scientific article published in May 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis. |
scientific article published in May 2013 |
Statements
Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis. (English)
1 reference
Keiko Shimamoto
1 reference
Tomoki Ito
1 reference
Yoshio Ozaki
1 reference
Hideki Amuro
1 reference
Akihiro Tanaka
1 reference
Tohru Nishizawa
1 reference
Yonsu Son
1 reference
Muneo Inaba
1 reference
Shosaku Nomura
1 reference
1 May 2013
1 reference
40
1 reference
7
1 reference
1074-1081
1 reference